Publications by authors named "R A Pellerito"

Polystyrene (PS) is an extremely stable polymer with a relatively high molecular weight and a strong hydrophobic character that makes it highly resistant to biodegradation. In this study, PS was subjected to biodegradation tests by () and () larvae. Specifically, six different experimental diets were compared: (i) fed with bran; (ii) fed only PS; (iii) fed only PS treated with HO; (iv) fed with bran; (v) fed only PS; and (vi) fed only PS treated with HO.

View Article and Find Full Text PDF

Purpose: Gastroenteropancreatic -neuroendocrine tumours (GEP-NETs) are commonly treated with surgical resection or long-term therapies for tumour growth control. Lutetium [Lu]-DOTA-TATE was approved for the treatment of GEP-NETs after the phase III NETTER 1trial demonstrated improved progression free survival, objective response rates and health-related quality of life (HRQoL) compared to high-dose somatostatin analogues. No real-world data exist on prescribing habits and clinically significant endpoints for [Lu]Lu-DOTA-TATE treatment in Italy.

View Article and Find Full Text PDF

Purpose: To study how the quantitative parameters of 18F-FDG PET imaging change with the emission scan duration (ESD) and the body-mass-index (BMI) in phantom and patients on a time-of-flight (TOF)-PET/CT system.

Methods: The image-quality phantom with (b-NEMA-IQ, BMI = 29.2 kg/m) and without (NEMA-IEC, BMI = 21.

View Article and Find Full Text PDF

Objective: Interstitial lung disease (ILD) is the leading cause of morbidity and mortality in systemic sclerosis (SSc) patients. We aimed to investigate the impact of sex on SSc-ILD.

Methods: EUSTAR SSc patients with radiologically confirmed ILD and available percentage predicted forced vital capacity (%pFVC) were included.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate incidental lung changes in asymptomatic cancer patients using [F]FDG PET/CT during the COVID-19 pandemic in Italy, where the virus was widespread.
  • Researchers analyzed data from 59 centers, comparing rates of interstitial pneumonia during various periods: during COVID (March 2020), pre-COVID (January-February 2020), and a control year (2019).
  • Results indicated a significant increase in interstitial pneumonia rates during the COVID period (7.1%) compared to pre-COVID (5.35%) and control (5.15%), particularly higher in Northern Italy, emphasizing the need to monitor such findings for early COVID-19 detection and management.
View Article and Find Full Text PDF